Lilly (Eli) & Co. (LLY)

followers · Follow 1 like

Sector:

HEALTH CARE

Industry:

BIOTECHNOLOGY & LIFE SCIENCES

SIC:

PHARMACEUTICAL PREPARATIONS

CEO:

David A. Ricks

Employees:

39000

LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, 46285

3172762000

lilly.com

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic colorectal cancer, and hepatocellular carcinoma. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic ax

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

Lilly (Eli) & Co. YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available